Two-Part Dose-Confirming Study of Pulsed Inhaled Nitric Oxide in Subjects With WHO Group 3 Pulmonary Hypertension Associated With COPD
Clinical trial NCT01728220 · COMPLETED
Trial details
- NCT number
- NCT01728220
- Sponsor
- Bellerophon Pulse Technologies
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-12-01
- Primary completion
- 2014-06-01
- Enrollment
- 159
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.